Yuya Tomioka
Kagoshima, 8908544, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
MicroRNA Signatures of Fulvestrant-Treated Luminal Breast Cancer Cells: Identification of Therapeutic Targets Regulated by miR-374b-5p.
Journal: International journal of molecular sciences
Published: June 29, 2026
The microRNA Expression Signature of Lung Adenocarcinoma Harboring EGFR Mutations: Identification of Therapeutic Targets for EGFR-TKI Combination Therapy.
Journal: International journal of molecular sciences
Published: June 02, 2026
MicroRNA Signatures in Lung Adenocarcinoma Metastases: Exploring the Oncogenic Targets of Tumor-Suppressive miR-195-5p and miR-195-3p.
Journal: Cancers
Published: June 11, 2025
Identification of Tumor Suppressive miR-144-5p Targets: FAM111B Expression Accelerates the Malignant Phenotypes of Lung Adenocarcinoma.
Journal: International journal of molecular sciences
Published: August 19, 2024
Improving visual acuity with nivolumab plus ipilimumab plus two cycles of chemotherapy following a diagnosis of lung adenocarcinoma with choroidal metastasis: A case report and literature review.
Journal: Respirology case reports
Published: October 31, 2023
The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma.
Journal: Cells
Published: June 20, 2023
Severe asthma remaining well-controlled after mepolizumab discontinuation: A case report and literature review.
Journal: Respirology case reports
Published: March 15, 2023
MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3.
Journal: FEBS letters
Published: December 02, 2022
Therapeutic Strategies for Metachronous Multiple Primary Lung Cancer
Journal: Kyobu geka. The Japanese journal of thoracic surgery
Published: February 07, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026